Public preview. Funding rounds, founders, and growth signals require a free account.

Imprimis Pharmaceuticals, Inc. (HROW, HROWL, HROWM)

Based on SEC filing data. A pharmaceutical corporation in San Diego has raised $10.7M in Series B equity funding and operates in the $25M–$100M revenue range. The company is in active growth mode with meaningful commercial traction in the pharma sector.

Series BPharmaSan Diego, CA

Total raised

$29.2M

Last round

Equity

$10.7M · May 2021

Stage

Series B

Status

Active

Founders & team

Co-founder, CEO

Co-founder, CTO

Head of Engineering

Head of Sales

🔒

Sign up to see founders

Free account unlocks founder names, LinkedIn profiles, and prior companies.

Create free account

Growth signals

Web traffic

Search interest

Social followers

Glassdoor rating

News mentions

Gov contracts

🔒

Sign up to see signals

Free account unlocks 5 full profiles per day. Pro removes the limit.

Create free account

Track Imprimis Pharmaceuticals, Inc. (HROW, HROWL, HROWM) on FlareSight

Get notified the moment Imprimis Pharmaceuticals, Inc. (HROW, HROWL, HROWM) files a new round, hires execs, or shows traction signals.

Create free account

About this data

FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.